Prognostic implications of cluster-defined phenotypes in AECOPD patients with bronchiectasis: A multicenter study

Q: What type of study is this?

This is a Human Clinical Trial study.

Jiaqi Pu; Yuanming Luo; Hailong Wei; Huiqing Ge; Huiguo Liu; Jianchu Zhang; Xianhua Li; Pinhua Pan; Xiu-Fang Xie; Mengqiu Yi; Lina Cheng; Hui Zhou; Jiarui Zhang; Lige Peng; Jiaxin Zeng; Xue-qing Chen; Qun Yi; Haixia Zhou

doi:10.1080/25310429.2025.2591498

Ask about this paper

Answers are grounded in this paper and cite their sources.

Abstract

BE independently predicts increased acute healthcare utilisation and exacerbation risk in AECOPD without affecting mortality. The SI-HR phenotype identification supports targeted management strategies for this heterogeneous population.Clinical Trial Registration: Chinese Clinical Trail Registry NO.: ChiCTR2100044625; URL: http://www.chictr.org.cn/showproj.aspx?proj=121626.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Pu et al. (2025) studied this question.

synapsesocial.com/papers/69403db42d562116f290e24d https://doi.org/10.1080/25310429.2025.2591498

View Full Paper

Ask AI

Bookmark

Share

Prognostic implications of cluster-defined phenotypes in AECOPD patients with bronchiectasis: A multicenter study

Ask about this paper

Abstract

Discussion

Cite This Study

Prognostic implications of cluster-defined phenotypes in AECOPD patients with bronchiectasis: A multicenter study

Ask about this paper

Abstract

Discussion

Cite This Study

Keep reading

Keep reading